SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-11-001956
Filing Date
2011-10-13
Accepted
2011-10-13 17:19:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422gen_10032011.htm SC 13G 197635
2 JOINT FILING AGREEMENT ex991to13g07422gen_10032011.htm EX-99.1 29218
  Complete submission text file 0000921895-11-001956.txt   228363
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 65 W WATKINS MILL RD GAITHERSBURG MD 20878
Business Address 65 W WATKINS MILL RD GAITHERSBURG MD 20878 2406320740
GENVEC INC (Subject) CIK: 0000934473 (see all company filings)

IRS No.: 232705690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60289 | Film No.: 111140198
SIC: 2834 Pharmaceutical Preparations